Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum AI/ML Innovations Inc C.AIML

Alternate Symbol(s):  AIMLF

AI/ML Innovations Inc. business operations is aligned to capitalize on the areas of artificial intelligence (AI) and machine learning (ML), with an initial focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive healthcare management solutions and precision support delivery across the health continuum. Its Salu Design Inc... see more

CSE:AIML - Post Discussion

AI/ML Innovations Inc > AI/ML Innovations' Health Gauge Licenses its Patented Tech.
View:
Post by Betteryear2 on Mar 28, 2022 12:47am

AI/ML Innovations' Health Gauge Licenses its Patented Tech.

- MedWatch™ to address needs in the $327 billion-dollar US diabetes market -

- License includes annual payment to Health Gauge of US$120,000, 2% gross sales royalty, US$2Million termination fee, and other royalties and fees -

TORONTO, ON / ACCESSWIRE / March 28, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its majority-owned subsidiary, Health Gauge Inc., has entered into a License Agreement with MedWatch Technologies, Inc. of Las Vegas, Nevada. MedWatch has agreed to license Health Gauge's patented health management technology ("Licensed Patent") and proprietary AI-powered software ("Licensed Software") for use in MedWatch's non-invasive blood glucose and other blood chemistry monitoring solutions for diabetes, and the health & wellness market.

AI/ML Innovations' Health Gauge Licenses its Patented Technology to MedWatch Technologies, Inc.

Comment by justus434 on Mar 28, 2022 1:47am
This post has been removed in accordance with Community Policy
Comment by austrochris on Mar 28, 2022 5:14am
wrong board !  Real great news today !
Comment by minepic on Mar 28, 2022 2:41pm
It is great news and the cash is all straight juice! The real value is in the patent itself. I imagine this is worth many millions!?
Comment by Prider on Mar 31, 2022 11:21am
I am a liitle surprised I thought we would have seen a little increase in share price.
Comment by minepic on Apr 05, 2022 2:49pm
I agree, however it is not a huge contract.  But what it shows is the value of the patent. It appears to me that ANY company that is returning biometrics to their customers is infringing on OUR patent!! Apple, Fitbit, Samsung, Google........... What is the real world value of the patent alone?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities